DOPTELET — AKARX INC, approved 2025-07-24 (NDA210238).
1,959 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.